Structure-Based Optimization of Coumarin hA3 Adenosine Receptor Antagonists

Author:

Matos Maria João12ORCID,Vilar Santiago2,Vazquez-Rodriguez Saleta2,Kachler Sonja3,Klotz Karl-Norbert3ORCID,Buccioni Michela4,Delogu Giovanna5ORCID,Santana Lourdes2,Uriarte Eugenio26,Borges Fernanda1ORCID

Affiliation:

1. CIQUP/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal

2. Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain

3. Institute of Pharmacology and Toxicology, University of Würzburg, 97078 Würzburg, Germany

4. School of Pharmacy, Medicinal Chemistry Unit, University of Camerino, 62032 Camerino, Italy

5. Department of Life Sciences and Environment—Section of Pharmaceutical Sciences, University of Cagliari, 09124 Cagliari, Italy

6. Instituto de Ciencias Químicas Aplicadas, Universidad Autónoma de Chile, 7500912 Santiago, Chile

Funder

European Regional Development Fund

H2020 Marie Sklodowska-Curie Actions

Universidade do Porto

European Social Fund

Funda??o para a Ci?ncia e a Tecnologia

Conseller?a de Cultura, Educaci?n e Ordenaci?n Universitaria, Xunta de Galicia

University of Santiago de Compostela

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3